In vivo labeling of the central GABA uptake carrier with 3H-Tiagabine.

[1]  B. Fjalland.  Inhibition by neuroleptics of uptake of 3H-GABA into rat brain synaptosomes. , 2009, Acta pharmacologica et toxicologica.

[2]  P. Suzdak,et al.  Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor. , 1991, European journal of pharmacology.

[3]  P. Suzdak,et al.  (R)‐N‐[4,4‐Bis(3‐Methyl‐2‐Thienyl)but‐3‐en‐1‐yl]Nipecotic Acid Binds with High Affinity to the Brain γ‐Aminobutyric Acid Uptake Carrier , 1990, Journal of neurochemistry.

[4]  F. Petty,et al.  Plasma GABA: A possible indicator of altered GABA function in psychiatric illness , 1984, Neuropharmacology.

[5]  C. R. Craig,et al.  Studies on γ‐Aminobutyric Acid Transport in Cobalt Experimental Epilepsy in the Rat , 1981, Journal of neurochemistry.

[6]  J. E. Vaughn,et al.  Inhibitory, GABAergic nerve terminals decrease at sites of focal epilepsy. , 1979, Science.

[7]  P. Krogsgaard‐Larsen,et al.  INHIBITION OF GABA UPTAKE IN RAT BRAIN SLICES BY NIPECOTIC ACID, VARIOUS ISOXAZOLES AND RELATED COMPOUNDS , 1975, Journal of neurochemistry.

[8]  P. Krogsgaard‐Larsen.  GABA synaptic mechanisms: Stereochemical and conformational requirements , 1988, Medicinal research reviews.

[9]  L. Yunger,et al.  Novel inhibitors of gamma-aminobutyric acid (GABA) uptake: anticonvulsant actions in rats and mice. , 1984, The Journal of pharmacology and experimental therapeutics.

[10]  S. Enna,et al.  Biochemical and electrophysiological characteristics of mammalian GABA receptors. , 1983, International review of neurobiology.